- 生化檢驗 (危急值)
- 細菌檢驗 (危急值)
- 病理(危急值)
- 血液學檢驗(異常值)
- 生化檢驗(異常值)
- 血液氣體分析(異常值)
- 藥物濃度(異常值)
- 鏡檢檢驗(異常值)
- 細菌檢驗 (異常值)
- 病毒檢驗 (異常值)
- 病理(異常值)
項目 |
危急值下限 |
危急值上限 |
單位 |
適用範圍 |
Glucose |
≦ 40 |
mg/dL |
|
|
K |
≦ 2.0 |
≧ 6.5 |
mmol/L |
|
Ca |
|
≧ 15 |
mg/dL |
|
項目 |
結果 |
附註 |
Bacterial Culture (CSF,Blood) |
N. meningitidis |
|
項目 |
結果 |
附註 |
骨髓染色體檢查 |
t(15;17)異常之急性前期骨髓白血病(Acute promyelocytic leukemia;APL) |
|
項目 |
異常值下限 |
異常值上限 |
單位 |
附註 |
WBC |
≦ 1,200 |
> 100,000 |
/μL |
|
< 3,000 |
|
/μL |
皮膚部 |
|
Hb |
≦ 5.0 |
|
g/dL |
|
Hct |
≦ 16 |
≧ 60 |
% |
|
PLT |
≦ 30,000 |
/μL |
||
APTT |
≧ 100 |
sec. |
||
PT |
≧ 50 |
sec. |
||
INR |
≧ 4.0 |
項目 |
異常值下限 |
異常值上限 |
單位 |
適用範圍 |
Ammonia |
≧ 150 |
μg/dL |
|
|
ALT |
≧ 400 |
U/L |
|
|
≧ 120 |
U/L |
皮膚部 |
||
AST |
≧ 400 |
U/L |
|
|
≧ 120 |
U/L |
皮膚部 |
||
Ca |
≦ 6.5 |
≧ 13 |
mg/dL |
|
Cl |
≦ 75 |
≧ 125 |
mmol/L |
|
Glucose |
≦ 50 |
≧ 600 |
mg/dL |
≧ 18 歲 |
≦ 50 |
≧ 400 |
mg/dL |
< 18 歲 |
|
K |
≦ 2.5 |
≧ 6.0 |
mmol/L |
|
≦ 2.5 |
≧ 10 |
mmol/L |
< 1 歲 |
|
Na |
≦ 115 |
≧ 160 |
mmol/L |
|
TG |
≧ 2000 |
mg/dL |
||
Troponin I |
≧ 0.6 |
ng/ml |
||
Hs-Troponin T |
≧ 100 |
ng/L |
||
CRP |
≧ 5 |
mg/dL |
限門診病患 |
項目 |
異常值下限 |
異常值上限 |
單位 |
附註 |
pCO2 |
≦ 20 |
≧ 70 |
mmHg |
|
pH |
≦ 7.2 |
≧ 7.6 |
||
pO2 |
≦40 |
mmHg |
項目 |
異常值下限 |
異常值上限 |
單位 |
附註 |
ACTM |
≧ 22 |
μg/mL |
||
AMIK |
AMIK-Peak ≧ 44 |
μg/mL |
||
AMIK-Trough ≧ 11 |
||||
AMIK LDEI-Trough ≧ 1.1 |
||||
CRBM |
Total ≧ 13.2 |
μg/mL |
||
Free form ≧ 3.3 |
||||
Digoxin |
≧ 2.0 |
ng/mL |
||
GENT |
≧ 13.2 |
μg/mL |
||
Lithium |
≧ 2.0 |
mmol/L |
||
PHNO |
≧ 33 |
μg/mL |
||
PTN |
Total ≧ 22 |
μg/mL |
||
Free form ≧ 2.2 |
||||
SAL |
≧ 33 |
mg/dL |
||
THEO |
≧ 16.5 |
μg/mL |
||
TCA |
≧ 500 |
ng/mL |
||
VALP |
Total ≧ 110 |
μg/mL |
||
Free form ≧ 11 |
||||
VANC |
Peak ≧ 44 |
μg/mL |
||
Trough ≧ 22 |
||||
Certican |
≧ 8.8 |
ng/mL |
||
CSA |
C0(用藥前) ≧ 400 |
ng/mL |
||
C2(藥後2小時) ≧1600 |
||||
AUC/hr ≧ 600 |
||||
Sirolimus |
≧ 15.4 |
ng/mL |
||
TACR |
≧ 22 |
ng/mL |
項目 |
結果 |
附註 |
||
Blood Smear |
Blast, Bacteria, Fungi |
|||
Body fluid |
||||
Urine routine |
Glucose ≧ 4+ (2.0 g/dl)且 Ketone ≧ 3+ |
項目 |
結果 |
附註 |
Gram stain smear (Pleural fluid、CSF、eye、biopsy、other sterile site body fluids) |
抹片陽性 |
|
Bacterial Culture/Fungus Culture (Pleural fluid、CSF、eye、biopsy、other sterile site body fluids) |
菌落染色(培養陽性) |
|
Blood culture |
抹片染色(培養陽性) |
|
VRE、VISA、PDR-Ab、PDR-Pa、CRE |
多重抗藥性菌種(醫療照護相關感染) |
|
India ink stain (CSF) |
陽性 |
|
Ordinary culture |
VRE、VISA、PDR-Ab、PDR-Pa、CRE、CRAb |
多重抗藥性菌種(醫療照護相關感染) |
Screen for CR-GNB |
CR-GNB |
多重抗藥性菌種(醫療照護相關感染) |
Screen for VRE |
Enterococcus species (VRE) |
多重抗藥性菌種(醫療照護相關感染) |
項目 |
結果 |
附註 |
C.difficile DNA amplification |
陽性 |
醫療照護相關感染 |
CMV PCR |
陽性 |
|
項目 |
結果 |
附註 |
病理檢查 |
惡性腫瘤 |
|
malignancy in an uncommon location or specimen type (e.g., hernia sac, intervertebral disk material, tonsil, etc.) |
不預期的病理發現或診斷 |
|
all kinds of unexpected malignancy |
||
absence of chorionic villi when clinically expected (potential ectopic pregnancy) |
||
change of a frozen section diagnosis after review of permanent sections |
||
significant infectious organisms identified on special stains |
最後更新: